Sexual dysfunction in Chinese women at different reproductive stages and the positive effect of hormone replacement therapy in the early postmenopause

References

• Harlow SD, Gass M, Hall JE, et al. Executive summary of the stages of reproductive aging workshop +10: addressing the unfinished agenda of staging reproductive aging. Climacteric. 2012;15(2):105–114.
   PubMed Web of Science ®Google Scholar
• Nazarpour S, Simbar M, Tehrani FR. Factors affecting sexual function in menopause: a review article. Taiwan J Obstet Gynecol. 2016;55(4):480–487.
   PubMed Web of Science ®Google Scholar
• So HW, Cheung FM. Review of Chinese sex attitudes and applicability of sex therapy for Chinese couples with sexual dysfunction. J Sex Res. 2005;42(2):93–101.
   PubMed Web of Science ®Google Scholar
• Zhang C, Tong J, Zhu L, et al. A population-based epidemiologic study of female sexual dysfunction risk in mainland China: prevalence and predictors. J Sex Med. 2017;14(11):1348–1356.
   PubMed Web of Science ®Google Scholar
• Heidari M, Ghodusi M, Rezaei P, et al. Sexual function and factors affecting menopause: a systematic review. J Menopausal Med. 2019;25(1):15–27.
   PubMedGoogle Scholar
• Chu K, Song Y, Chatooah ND, et al. The use and discontinuation of hormone replacement therapy in women in South China. Climacteric. 2018;21(1):47–52.
   PubMed Web of Science ®Google Scholar
• Zhou Y, Li C, Jin F, et al. Prevalence and predictors of sexual function in midlife partnered Chinese women assessed by two simple indicators: sexual frequency and sexual desire. J Obstet Gynaecol Res. 2019;45(1):210–216.
   PubMed Web of Science ®Google Scholar
• Du J, Ruan X, Gu M, et al. Prevalence of and risk factors for sexual dysfunction in young Chinese women according to the Female Sexual Function Index: an internet-based survey. Eur J Contracept Reprod Health Care. 2016;21(3):259–263.
   PubMed Web of Science ®Google Scholar
• Tong J, Zhang C, Zhu L, et al. Sexual dysfunction in perimenopausal women based on a national epidemiological survey in China. Climacteric. 2019;22(2):190–194.
   PubMed Web of Science ®Google Scholar
• Wong ELY, Huang F, Cheung AWL, et al. The impact of menopause on the sexual health of Chinese Cantonese women: a mixed methods study. J Adv Nurs. 2018;74(7):1672–1684.
   PubMed Web of Science ®Google Scholar
• Zilio Rech CM, Clapauch R, Bouskela E. Sexual function under adequate estrogen therapy in women after oophorectomy versus natural menopause. J Womens Health. 2019;28(8):1124–1132.
   Web of Science ®Google Scholar
• Taylor HS, Tal A, Pal L, et al. Effects of oral vs transdermal estrogen therapy on sexual function in early postmenopause: ancillary study of the Kronos Early Estrogen Prevention Study (KEEPS). JAMA Intern Med. 2017;177(10):1471–1479.
   PubMed Web of Science ®Google Scholar
• Santoro N, Worsley R, Miller KK, et al. Role of estrogens and estrogen-like compounds in female sexual function and dysfunction. J Sex Med. 2016;13(3):305–316.
   PubMed Web of Science ®Google Scholar
• Benetti-Pinto CL, Rosa ESA, Yela DA, et al. Abnormal uterine bleeding. Rev Bras Ginecol Obstet. 2017;39(7):358–368.
   PubMedGoogle Scholar
• Sun X, Li C, Jin L, et al. Development and validation of Chinese version of Female Sexual Function Index in a Chinese population-a pilot study. J Sex Med. 2011;8(4):1101–1111.
   PubMed Web of Science ®Google Scholar
• Gerstenberger EP, Rosen RC, Brewer JV, et al. Sexual desire and the Female Sexual Function Index (FSFI): a sexual desire cutpoint for clinical interpretation of the FSFI in women with and without hypoactive sexual desire disorder. J Sex Med. 2010;7(9):3096–3103.
   PubMed Web of Science ®Google Scholar
• Lou WJ, Chen B, Zhu L, et al. Prevalence and factors associated with female sexual dysfunction in Beijing, China. Chin Med J. 2017;130(12):1389–1394.
   PubMed Web of Science ®Google Scholar
• Dąbrowska-Galas M, Dąbrowska J, Michalski B. Sexual dysfunction in menopausal women. Sex Med. 2019;7(4):472–479.
   PubMed Web of Science ®Google Scholar
• Scavello I, Maseroli E, Di Stasi V. Sexual health in menopause. Medicina. 2019;55:559.
   PubMedGoogle Scholar
• Allen MS, Walter EE. Health-related lifestyle factors and sexual dysfunction: a meta-analysis of population-based research. J Sex Med. 2018;15(4):458–475.
   PubMed Web of Science ®Google Scholar
• Thomas HN, Neal-Perry GS, Hess R. Female sexual function at midlife and beyond. Obstet Gynecol Clin North Am. 2018;45(4):709–722.
   PubMed Web of Science ®Google Scholar
• Ruan X, Mueck AO. Impact of smoking on estrogenic efficacy. Climacteric. 2015;18(1):38–46.
   PubMed Web of Science ®Google Scholar
• Mueck AO, Seeger H. Smoking, estradiol metabolism and hormone replacement therapy. Drug Res. 2003;1:1–11.
   Google Scholar
• Maseroli E, Scavello I, Vignozzi L. Cardiometabolic risk and female Sexuality-Part I. risk factors and potential pathophysiological underpinnings for female vasculogenic sexual dysfunction syndromes. Sex Med Rev. 2018;6(4):508–524.
   PubMed Web of Science ®Google Scholar
• Maseroli E, Fanni E, Cipriani S, et al. Cardiometabolic risk and female sexuality: focus on clitoral vascular resistance. J Sex Med. 2016;13(11):1651–1661.
   PubMed Web of Science ®Google Scholar
• Baber RJ, Panay N, Fenton A. 2016 IMS recommendations on women’s midlife health and menopause hormone therapy. Climacteric. 2016;19(2):109–150.
   PubMed Web of Science ®Google Scholar
• Ruan X, Mueck AO. Chinese obstetrician-gynecologists still need more education in menopausal hormone therapy. Menopause. 2014;21(11):1170–1172.
   PubMed Web of Science ®Google Scholar
• de Villiers TJ, Hall JE, Pinkerton JV, et al. Revised global consensus statement on menopausal hormone therapy. Climacteric. 2016;19(4):313–315.
   PubMed Web of Science ®Google Scholar
• Martins WP, Lara LA, Ferriani RA, et al. Hormone therapy for female sexual function during perimenopause and postmenopause: a cochrane review. Climacteric. 2014;17(2):133–135.
   PubMed Web of Science ®Google Scholar
• Nastri CO, Lara LA, Ferriani RA, et al. Hormone therapy for sexual function in perimenopausal and postmenopausal women. Cochrane Database Syst Rev. 2013;6:CD009672.
   Google Scholar
• Mueck AO, Seeger H, Bühling KJ. Use of dydrogesterone in hormone replacement therapy. Maturitas. 2009;65(suppl 1):S51–S60.
   PubMedGoogle Scholar